Skip to main content
Veterinary Medicines

NEOMICINA LABIANA 500.000 UI/g POLVO ORAL

Authorised
  • NEOMYCIN SULFATE

Product identification

Medicine name:
NEOMICINA LABIANA 500.000 UI/g POLVO ORAL
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Pig
  • Cattle (calf)
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    500000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        20
        day
    • Cattle (calf)
      • Meat and offal
        30
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
  • Cenavisa S.L.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 327 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."